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1. Introduction 
The need for reconstructive surgery of bones is continuously increasing along with the 
ageing of the population as well as the increase of traumatologic injuries. In the United 
States, the number of bone grafts was 350,000 in 2001. Nowadays, over 500,000 bone graft 
procedures are performed annually, and approximately 2.2 million worldwide (Giannoudis 
et al., 2005). The estimated cost of these procedures approaches US$2.5 billion per year. 
Hence, the considerable demand for these replacement procedures cannot be met solely by 
using donor material. Therefore, superior synthetic orthopaedic materials and techniques 
should be available on the market for clinical practice. Adjustable porosity, bioactivity, 
identical biomechanics, as well as all the other tissue-friendly properties to bone are central 
for achieving a durable, bonding-like, interface between the synthetic material and bone 
(Aho et al., 2004). Actually, modern material technology would have all the know-how for 
preparing excellent synthetic orthopaedic materials. Autografts are still regarded as optimal 
reconstruction material, because of the lack of good enough synthetic materials. However, in 
orthopaedics, the demands for synthetic materials could be fulfilled by using composite 
structures. In fact, it is possible to mimic better the structures of living materials, like bone, 
cartilage or teeth using composite structures. Therefore, there is still a constant need to 
search for better synthetic bone substitute materials for tissue engineering (Chung et al., 
2007).  
2. Clinical background 
Typically, the synthetic bone substitute materials have traditionally been in the form of 
blocks, granules, mass, or gel. Although these kinds of materials are commercially available 
under several different trademarks, only a few defects are so far repaired using synthetic 
bone substitutes in clinical practice, in ca. 10% of cases (Stevens et al., 2008). Table 1 shows 
different types of materials that are employed as bone substitutes. Basically, only metallic 
materials, of the commercially available synthetic biomaterials, are mechanically good 
enough to reconstruct large cortical bone defects. Of donor materials, autograft is bone that 
is removed from the patient's own body, whereas allograft is bone that is removed from the 
same species (i.e. other humans). In addition, xenograft is also of biological origin; it is 
extracted from the inorganic phase of mammal bone but of some other species, typically e.g. 
that of neat. In fact, the use of autograft is drastically limited, because of the lack of 
availability and donor site morbidity limits. On the other hand, the risk of infection 
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transmission is a major concern that restricts the use of allografts and xenografts (Kappe et 
al., 2010; Tadic & Epple, 2004).  
In the bone reconstructions, polymeric materials, such as, e.g. polymethylmethacrylate 
(PMMA) or polyethylene (UHMWPE), have been employed as PMMA-based bone cements 
or as acetabular cups of hip prostheses, for several years. In fact, their use will further 
increase in tissue engineering (Boyer et al., 2009; Gasser, 2000; Wang, 2003). Therefore, 
synthetic polymers used as biomaterials have sometimes even been called biopolymers. 
However, the concept of biopolymers has been traditionally reserved for the polymers, i.e. 
macromolecules that living organisms produce, e.g. cellulose, proteins, chitin, RNA and 
DNA. Therefore, biopolymers are also polymers that are employed in biomedical 
applications (Fukushima et al., 2011; Vieira et al., 2011). 
 
ALLOGRAFT AUTOGRAFT 
Infection risk 
Management of bone bank is difficult 
Expensive 
Lack of availability  
Damage to healthy bone tissues 
Secondary surgical procedure needed 
METALLIC MATERIALS POLYMER-BASED MATERIALS 
Metal-bone interface mechanical 
Loosening risk 
Stress shielding 
High elasticity moduli not optimal for bone 
Release of nanoparticles 
Residual toxic monomers, e.g.  
Risk of exothermic effects, hypotonia, or 
heart and lung complications 
Risk of wear debris 
BIOCERAMICS AND BIOACTIVE 
GLASSES 
OTHER, e.g. Xenografts 
Brittleness  
Stress shielding  
High modulus of elasticity 
Infection risk 
Low strength 
Table 1. The main material categories to reconstruct bone, and some of their typical 
disadvantages 
3. Methods to study materials for bone reconstruction 
Biomaterial research is focused on the design and development of synthetic materials for 
surgery. Therefore, a multidisciplinary research environment, i.e. combining medical 
sciences and biotechnology with chemistry, biology and physics, is needed. More precisely, 
the required testing categories include (1) chemical analysis, (2) biomechanical engineering, 
(3) biological testing (biomimetic biomineralization, cell culture and in vivo studies), and (4) 
advanced imaging technology. In fact, in order to develop synthetic materials for bone 
reconstruction, a well-equipped biomaterial research laboratory has a wide range of 
instruments, such as microcomputed tomography (micro-CT), nuclear magnetic resonance 
(NMR) and fourier transform infrared spectroscopy (FTIR) spectrometers, and 
thermoanalytical techniques: e.g. differential scanning calorimeter (DSC) or thermomechanical 
analyzer (TMA), high performance liquid chromatography (HPLC), scanning electron 
microscope (SEM) or transmission electron microscope (TEM), and material testing 
machines (e.g. Lloyd LRX or Instron equipments). In addition, facilities for the synthesis of 
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organic molecules and biopolymers are needed. To carry out biological testing, the cell 
culture and histological laboratory, standard stainings and molecular biology techniques 
should be available, as well as several light microscopes and a computer-based 
histomorphometric analysis system (e.g. Aho et al., 2004; Meretoja et al., 2006; Puska et al., 
2003; Silva Nykänen et al., 2011). 
4. Composites for bone reconstruction 
Modern synthetic chemistry has reached the point where it is possible to prepare molecules 
in almost any structure. Methods are available to produce a wide variety of useful materials, 
such as bioactive or chiral self-assembled polymer structures (Cui et al., 2010; Wang, 2008). 
For example, phosphorus-containing biopolymers have been synthesized and developed as 
polymeric candidates for potential tissue engineering applications (e.g. 
poly[bis(methacrylate)]phosphazene, PMAP) (Silva Nykänen et al., 2011). In the polymeric 
structure, the presence of phosphorus may improve the biocompatibility of polymers by 
enhancing their tissue contact. Actually, phosphorus is an essential element in all living 
systems, e.g. as a key part of the phosphodiester bonds in DNA and RNA. 
In addition, in the form of thermosets and thermoplastics, both biostable and biodegradable 
polymers (e.g. polycaprolactone, PCL and PMMA) have been studied, largely for tissue 
engineering (Aho et al., 2004; Middleton & Tipton, 2000; Morita et al., 1998; Puska et al., 
2003; Wang, 2003). Structurally, the form of these polymers can be linear, cross-linked or 
interpenetrated polymer networks (IPNs). IPNs are three-dimensional physically or 
chemically cross-linked polymeric materials that include two independent networks 
without any covalent bonds between them (Feng et al., 2004; Sperling 1994). Polymer 
composites are combinations of two or more components, usually containing an inorganic 
phase and a polymer phase that are essentially insoluble in each other (Gasser, 2000). 
Polymers have typically lower modulus and deformation resistance than the inorganic 
phase. Thus, attempts are made to adjust the mechanical properties of polymeric materials 
to approximate those of bone, using a composite structure. In fact, the matrix polymer- 
containing filling components result in a complicated interaction between the properties of 
every constituent phase, i.e. (a) the matrix, (b) filling components, and (c) the interfacial 
region between the filling components and the matrix polymer (Wang, 2003). 
4.1 Chemistry of PMMA-based bone cements 
For over 40 years, the best known polymeric material or “biopolymer” has been PMMA-
based bone cement. Typically, PMMA-based bone cements are employed in many 
orthopaedic operations, e.g. in total joint replacement surgery, substitutes in 
vertebroplasty/kyphoplasty, or as filling material in trauma surgery (Boyd et al., 2008; 
Lewis, 2009). Commercially available bone cements are made of (a) a powder component 
consisting of PMMA polymer or related block copolymers and (b) a liquid component made 
of methylmethacrylate (MMA) or related monomer liquids. Just before the clinical 
procedure, bone cement is fabricated by combining the powder and the liquid component 
together. In fact, the monomer phase dissolves the powder component and, thereafter, it 
autopolymerizes within 10 – 15 min, resulting first in a mouldable viscous dough after 3-7 
min, and then a very dense cured PMMA-based bone cement. More precisely, the powder 
component contains PMMA or related block copolymer beads (diameter 50 μm), an initiator, 
and radio-opaque substances. The liquid is methylmethacrylate (MMA) monomer or related 
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methacrylic monomers that polymerise in the presence of the initiator. Structurally, PMMA-
based bone cements are formed of typical linear polymers. However, PMMA-based bone 
cement can also be modified in the form of a semi-IPN structure by adding small amounts of 
cross-linking monomers (e.g. 2-30 wt% of ethylene glycol dimethacrylate, egdma) to the 
liquid phase (Lewis, 2009; Puska et al., 2003, 2004). In future tissue reconstruction 
applications, the acrylic polymer matrix will most probably also be modified using dendritic 
macromonomers. 
In joint replacement surgery, the main function of PMMA-based cement is to transfer body 
weight in order to increase the load-bearing and fixation capacity of the reconstruction area. 
On the other hand, PMMA-based cement is morphologically very dense, thus not allowing 
bone ingrowth. In addition, the exothermal polymerization of MMA in vivo might cause a 
risk of thermal and chemical necrosis of bone. However, in most cases, PMMA-based 
cements have been successfully utilized in orthopaedic surgery for many decades (Lewis 
2009; Puska et al., 2003). Therefore, interest has arisen in developing more biocompatible 
PMMA-based cements. In fact, their weakest link is the dense non-bioactive cement-bone 
interface that is a barrier to direct fracture healing. Basically, it is possible to make the 
properties of PMMA-based bone cements more tissue-friendly, as an example of a 
functional active composite structure that is porous and bioactive. The porosity and 
bioactivity are created by filling components in both powder and liquid components, thus 
slightly changing the content. 
In terms of bioactivity, PMMA-based cements are combined with inorganic substances, i.e. 
bioactive glasses, hydroxyapatite. In the literature, a number of bioactive PMMA cements 
are presented. Bioactive bone cements are normally successfully obtained when the PMMA 
matrix contains an appropriate concentration of bioactive ceramics. For example, Shinzato et 
al. have reported that bioactive PMMA cements containing bioactive substances have 
significantly higher bone-bonding strength than plain PMMA cement (Shinzato et al., 2001). 
However, the presence of fairy large concentrations of ceramics in PMMA can disfavour the 
mechanical properties. Especially if adhesion between the PMMA matrix and the particles of 
ceramics is missing, particles often behave like voids as crack nucleation (Abboud et al., 
2000).  
4.2 Bifunctional acrylic resins as matrix components 
Bifunctional acrylic resins contain monomers with two active bonding positions. Originally, 
they were developed for dental applications (Schweikl et al., 2006), but nowadays these 
monomers have also been investigated for orthopaedic surgery. The best known 
bifunctional methacrylates are bisphenol-A-glycidyldimethacrylate (BisGMA) and 
triethylene glycol dimethacrylate (TEGDMA), Fig. 1. BisGMA-based bone cements are 
developed to reduce the problems encountered with bioactive PMMA cements (Boyd et al., 
2008; Smit et al., 2008). Actually, highly cross-linked polymers, such as the BisGMA-based, 
are the only polymers that are strong enough (e.g. compression strength: >100 MPa) to 
withstand the different types of stresses of cortical bone (Gheduzzi et al., 2006). Especially 
Japanese researchers have been very active in studying BisGMA-based cements (Kobayashi 
et al., 1999). 
One commercially available highly cross-linked biostable cement is Cortoss® (Orthovita, 
Malvern, USA) that comprises three main resins: BisGMA and ethoxylated bisphenol A 
dimethacrylate (BisEMA) and TEGDMA as a viscosity modifier. In addition, Cortoss® 
contains reinforcing particles of silica, barium boro-aluminosilicate glass and combeite glass 
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Fig. 1. The molecule structures of compounds containing methacrylate group: (a) bisphenol-
A-glycidyldimethacrylate, BisGMA, (b) methylmethacrylate, MMA, (c) triethylene glycol 
dimethacrylate, TEGDMA, and (d) methacryloyloxypropyltrimethoxysilane, MPS. The 
circles show active bonding positions that are able to react with other monomers, i.e. 
necessary for the curing/hardening of acrylic bone cement 
ceramic, as well as a silane coupling agent (Boyd et al., 2008; Gheduzzi et al., 2006; Smit et 
al., 2008). The setting time of Cortoss® cement is reported to be between 4 and 8 min, thus 
very suitable for bone reconstruction. The main drawbacks of Cortoss® are its missing 
porosity and, in some cases, the biodegradation of matrix polymer. In addition, the cements 
that are mechanically very strong may introduce stress shielding that is observed if the 
material exhibits much greater stiffness compared to the modulus of cortical bone. Another 
potential problem occurs if BisGMA-based cements are employed in vertoplasty. The 
extreme strengthening of one vertebra may potentially cause a fracture in the neighbouring 
osteoporotic vertebra. In fact, these acrylic monomers are also identified as being harmful in 
mammalian cells. Some of these substances can induce, e.g. gene mutations, probably 
because of the covalent binding to DNA via Michael addition (Schweikl et al., 2006). 
4.3 Biodegradable polymers as matrix polymers 
Since the mid-1990s, biodegradable polymer composites appear to have been studied for the 
applications of tissue engineering (Aho et al., 2004; Meretoja et al., 2006; Middleton & Tipton, 
2000; Törmälä, 1992; Wang, 2003). In these, the typical matrix polymers are polylactide (PLA), 
polycaprolactone (PCL), polypropylenefumarate (PPF) or any of their copolymers. Basically, 
biodegradable polymer composites are prepared by mixing bioactive compounds in a certain 
fragment volume with melt/dissolved polymer (Rezwana et al 2006, Wang 2003). Typically, 
matrix polymers in these biocomposites are delivered as viscous liquids or mouldable pastes. 
The intermediate phase of the biodegradable polymer composites is a soft mouldable mass 
that hardens relatively fast in 20 s – 1 min. The compression strength of these biodegradable 
composites is rather low, between 10 and 50 MPa. However, the biodegradable composites 
containing bioactive compounds are osteoconductive and easy to handle. Therefore, they are 
very suitable as bone grafting substitutes for small cancellous bone or cartilage defects (Aho et 
al., 2004; Meretoja et al., 2006; Wang, 2003). 
www.intechopen.com
 Advances in Composite Materials - Analysis of Natural and Man-Made Materials 
 
60 
Some years ago, Aho et al. reported one injectable biodegradable composite that contains 
particles of bioactive glass embedded in poly(caprolactone-co-D,L-lactide) matrix. The glass 
particles in matrix polymer resulted in osteoconductivity (Aho et al., 2004). In addition, 
Leeuwenburgh et al. have developed a nanoceramic (CaP) polymer composite consisting of 
oligo(poly(ethylene glycol)fumarate) as matrix (Leeuwenburgh et al., 2007). Kim et al. have 
investigated an injectable PPF that is porous after injection. The porous structure is created in 
situ by CO2 bubbles that are generated in a reaction of bicarbonate salt and weak acid (Kim et 
al., 2009). Łukaszczyk et al. have introduced a poly(3-allyloxy-1,2-propylene)succinate-based 
biodegradable bone cement that would have a tendency to set in situ in vivo by cross-linking 
poly(3-allyloxy-1,2-propylene)succinate (PSAGE) with MMA and methacrylic anhydride 
(Lukaszczyk et al., 2007). In fact, injectable PPF and methacrylated polyanhydrides have 
aroused much interest; one reason is their in situ curing capacity. 
5. Biomechanics of composites for bone reconstruction 
In terms of filling particles, the properties of matrix polymers, such as stiffness, thermal 
expansion, creep resistance or fracture toughness, can be changed. If particles are 
incorporated in polymers, it makes the final material stiffer or harder. On the other hand, 
the tensile strength decreases with an increasing amount of inorganic particles. Therefore, it 
is important to know the type and shape of the filling particles to be able to make the right 
choice. In fact, the shape of the component, e.g. particles vs. fibres, depends on the 
application to which the load-bearing forces are directed (Garoushi et al., 2006; Puska et al., 
2004; Wang, 2003).  
5.1 Reinforcing components 
The properties of composites are dependent on the type, volume fraction and orientation of 
the filling substance. In the case of isotropic 3D reinforcing, it can be obtained using spheres, 
granules or short fibres (Wang 2003). Table 2 shows some typical categories of osteogenetic 
composites for bone reconstruction. In terms of fibre-reinforced composites (FRCs), 
reinforcing fibres are employed in two forms: (a) continuous unidirectional or (b) chopped. 
The other main parameters affecting mechanical properties of FRC include: (1) the exact 
composition of fibres and polymer matrix, (2) the orientation and quantity of fibres, (3) the 
adhesion between fibres and polymer matrix, and (4) the impregnation of the fibres by the 
resin matrix. Moreover, the fibre length also significantly influences the mechanical 
properties (Behr et al., 2000; Thomason, 2007). In fact, the reinforcing effect of fibres can be 
predicted using the so-called Krenchel’s factor. In the Krenchel’s analysis, the orientation of 
the fibres and the applied load depend on each other. Continuous unidirectional fibres give 
the highest mechanical properties, but only anisotropically, matching the direction of the 
fibres (Krenchel, 1963). In tissue engineering, the reinforcing fibres of composites can be 
made of E-glass, bioactive glass, polyethylene, the family of aromatic amides (i.e. aramid), 
carbon, graphite, titanium, or fibres of natural origin. 
5.2 Interfacial aspects 
To understand the reinforcing phenomenon of polymer composites, it is very important to 
understand the adhesion between the matrix polymer and the reinforcing substances. It 
requires a lot of information to understand, e.g. how materials interact with each other, 
what kinds of coupling systems there are, the interface, and the failure mechanism. Failures 
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often occur within the polymer or at the interface. To be precise, the surface of fillers can be 
modified either using (1) surface treatment or (2) chemical grafting. In fact, the surface 
roughness also has a significant effect on wettability by monomers or coupling agents. 
Using some kind of chemical surface treatment, e.g. using MPS-silane (Fig.1), a covalent 
bonding can be obtained between the polymer matrix and inorganic fillers at molecular level 
(Fig. 2) (Vallittu, 1995, 1998; Puska et al., 2009b). 
 
Type of polymer composite Compression strength Advantages 
Biodegradable matrix polymer with 
bioactive glasses or ceramics, Refs1 
Low degree,  
weak ~10-50 MPa 
Osteogenic and  
bone ongrowth 
Biostable matrix polymer with 
calcium ceramics, Ref2 
Moderate  
strength ~80 MPa 
Slightly porous, osteogenic  
and bone on- and ingrowth 
Modified PMMA-based bone 
cement, Ref3 
Moderate  
strength ~70 MPa 
Interconnected porosity, 
osteogenic and bone on-  
and in-growth 
Fibre-reinforced and highly 
crosslinked acrylic polymer, Ref4 
High degree,  
strength adjustable 
>150 MPa 
Non-porous, optimal strength 
for cortical bone, tailor-made 
elasticity, osteogenic 
Refs1: Aho et al., 2004; Rezwana et al., 2006; Wang, 2003;  
Ref2: Puska et al., 2009a; Ref3: Puska et al., 2004; Ref4: Garoushi et al., 2006 
Table 2. As bone substitutes, the osteogenic composites grouped according to their 
composition and biomechanics 
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Fig. 2. Simplified presentation of glass fibre pre-impregnation with PMMA; these thin 
PMMA layers can be covalently bonded to the glass surface. (a) A plain tiny glass fibre 
strand and MPS (b) The formation of silanized layer (siloxane layer) (c) The deposition of 
PMMA layer 
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6. Osteoconductivity and porosity of synthetic biomaterials 
Osteoconduction is a characteristic of bone reconstructive materials that favours the spread 
of osteogenetic cells, i.e. osteoblasts and osteocytes, on the surface of the material. Bioactive 
materials are designed to induce a specific biological activity (Einhorn, 1995; Hench & 
Wilson, 1984). In fact, the bioactive properties of composites can be altered by embedding 
the biologically active substances, such as drugs, bisphosphonates, antimicrobial agents, 
proteins, growth factors, enzymes and DNA into either pore-generating filler or into 
reinforcing components. In the case of tissue engineering, the matrix polymer could also 
imply bioactivity or it could contain biologically active components. In this context, 
bioactivity is surface reactivity that has the ability to bond with both bone and subcutaneous 
tissue. Basically, bioactive materials have been shown to form a direct connection to living 
bone through a Ca-P-rich layer. The main categories of bioactive compounds that are 
utilized as filling components are: (a) bioactive glasses (BAG) or apatite wollastonite glass 
ceramics (AW-GC), (b) calcium phosphates, and (c) calcium sulphates. Bioactive bone 
substitutes are normally successfully obtained when the matrix polymer contains 
appropriate concentrations of bioactive fillers, often more than 50 wt%. For example, 
bioactive PMMA-based bone cements containing AW-GC or BAG have significantly higher 
bone-bonding strength than plain PMMA cement (Kenny & Buggy, 2003).  
6.1 Bioactive glasses 
The most important feature for producing bioactive glasses is based on the specific 
composition of the glass, where the amount of oxides is: SiO2 < 60 wt%, a high Na2O and 
CaO content, and a high CaO/P2O5 ratio (Gomez-Vega et al., 2000; Zhang et al., 2010; Hench 
& West, 1996). Bioactive glasses can be produced in various shapes, e.g. as granules, spheres 
or in fibre form. In the case of PMMA-based bone cements, the biostable matrix polymer can 
be easily incorporated using bioactive glass substances. Namely, the bioactive substances 
used as fillers in the composite structure of inert polymer stimulate bone ingrowth into the 
outermost porous structure, thus accelerating the overall healing process.  
6.2 Calcium-phosphate (CaP)-based fillers 
The family of calcium phosphates (CaP), such as tricalcium phosphate (TCP) and 
hydroxyapatite (HA), are osteoconductive materials. In mammals, hydroxyapatite 
Ca10(PO4)6(OH)2, is the main mineral of hard tissues (Jarcho et al., 1976). Natural HA 
isolated from mammal bone has very good chemical and biological affinity to bone tissue. 
However, HA is nowadays prepared synthetically. In fact, natural and synthetic HA are 
only two compounds in the category of CaP cements (Tadic & Epple, 2004). Other 
compounds are tricalcium phosphate (TCP), tetracalcium phosphate (TTCP), and calcium 
pyrophosphate (CPP), dicalcium phosphate anhydride (DCPA) and dicalcium phosphate 
dehydrate (DCPD) (Chen et al., 2009; Heini & Berlemann, 2001). The manufacturing of CaP 
cements involves sintering at high temperatures with exclusion of H2O.  
6.3 Calcium-sulphate-based fillers 
Calcium-sulphate (CaSO4)-based materials have been utilized in the treatment of bone 
cavities for many decades (Abramo et al., 2010). Some alternatives of calcium-sulphate 
powders set in contact with water and the solid form contains two molecules of crystal 
water. Compared to CaP cements, CaSO4-based materials imply biodegradation capacity. 
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Actually, plain CaSO4-based cements disappear from the body in one year (Jung et al., 2010). 
Therefore, CaSO4 cements are utilized as bone graft substitute in reconstruction in the distal 
radius. In terms of osteconductivity, CaSO4-based materials seem to be good filling 
components when incorporated in inert polymer matrices (Fig. 3) (Puska et al., 2009a). 
 
 
Fig. 3. On the left, structure of plain bifunctional polymer composite containing CaSO4-
based materials (50wt%) before SBF soaking. On the right, the effect of biomimetic 
mineralization (in SBF solution), i.e. the formation of hydroxyl apatite is significant.  
The length of the measuring rod is 20 μm (Ref. Puska et al., 2009a) 
 
 
Fig. 4. The porosity of the outermost surface, i.e.  in the modified PMMA-based bone cement 
structure after the specimen has been soaked in SBF solution. The length of the white 
measuring rod is 100 μm 
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6.4 Porosity in biocomposites 
In biomaterials, the function of porosity is to provide a scaffold for new bone tissue 
ingrowth. In particular, the porosity should be continuous and interconnected, where most 
of the pores should be large enough (100 - 500 μm) (Deville et al., 2006; Itälä et al., 2001). 
Figure 4 shows the outermost surface of modified PMMA-based bone cement. In fact, 
porosity formation will increase the contact surface between the living tissue and the 
scaffold, thus holding the implant much more tightly in place. The porous structure can be 
created in situ in vivo using so-called pore-generating fillers that are bioabsorbable particles 
embedded inside non-resorbable matrix polymer. After the implantation, these fillers will 
degrade in contact with body fluid. Ideally, porosity should develop fast enough after the 
material has been implanted into living tissue, i.e. within the first few days. However, the 
porosity formation also decreases the mechanical properties of the cured bone cement 
(Puska et al., 2003, 2004). 
7. Clinical demands 
Most biological materials (e.g. bone, dentin, or cartilage) also tend to be composites. Natural 
composites quite often have extremely hierarchical structures, in which particulate, porous, 
and fibrous structures are present. In fact, the aim of composite technology for bone 
reconstruction is to tailor the properties of biomaterials closer to those of repaired hard 
tissue (e.g. cartilage or cortical bone). Therefore, optimal reconstruction of large-size bone 
damages is very challenging, because bone as a biological composite is porous, thus 
allowing constant circulation of fluids and different types of bone cells, minerals etc. (Aho et 
al., 2004; Itälä et al., 2001; Meretoja et al., 2006; Puska et al., 2003). In addition, if artificial 
materials are implanted into bone, there is a constant risk of infections. The properties of 
bone vary, i.e. depending on the anatomic location in the skeleton and the bone (Fig. 5). 
More precisely, biological criteria for reconstruction materials are classified according to the 
size, form and quality of bone (Ritchie et al., 2006). In addition, cortical bone as load-bearing 
sites of the skeleton also has specific elastic, anisotropic and heterogeneous structural 
properties that differ significantly from cancellous bone. More precisely, the compression 
strength of cortical bone is reported to be between 100 and 200 MPa, whereas the 
compression strength of cancellous bone is only between 2 and 12 MPa (Reilly & Burstein, 
1974, Lotz et al., 1991).  
In the case of bone reconstruction, the choice of the best available biomaterial has to be 
decided from among the alternatives of the categories presented in Table 1. Therefore, the 
clinician has to make the decision according to information based on the availability of 
materials versus the condition of the patient that depends on his/her age, physical size 
(height/ weight), health, and genotype, as well as the shape, size and location of the defect. 
After operation, when biomaterials are in very close contact with bone, the new bone 
formation occurs as an osteoconductive growth, i.e. osseointegration on the surface of the 
material (ongrowth) or into the material (ingrowth) if there is a suitable amount of porosity 
and bioactivity (Aho et al., 2004). In terms of osteoinduction, biomaterial also accelerates 
new bone formation by chemical means (e.g. bioactive glasses) (Hench & Wilson, 1984; 
Hench & West, 1996). 
Sometimes, bone does not create a durable ongrowth to the biomaterial’s surface, e.g. in the 
case of encapsulation, when a so-called foreign body reaction takes place. In order to avoid 
this, the employed biomaterial should have bioactivity and porosity, thus allowing a tight 
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osseointegration or even bone ingrowth into the interconnected 3D porous interfaces. On 
the other hand, in the case of totally or partially biodegradable biomaterials, the remodelling 
of new bone and the degradation of biomaterial should occur simultaneously.  
 
 
Fig. 5. Biomechanically, the highest load-bearing capacity of bone is needed on the 
outermost sites of bone. Therefore, if these parts of bone are reconstructed, the mechanical 
properties of the synthetic bone substitute should be similar to those of bone  
7.1 Biological function: Bone grafting 
Bone grafting is a surgical procedure, in which the bone defect or the missing bone is 
replaced with natural or artificial substitutes. More precisely, these are substitutes of natural 
origins (donor materials) or synthetic bone substitutes, i.e. inorganic compounds, polymeric 
materials, or biocomposites. 
In fact, a highly sophisticated synthetic bone substitute should have: 
1. porosity allowing new bone ongrowth and ingrowth, 
2. bioactivity (i.e. osteoconductivity and/or osteoinductivity),  
3. suitable mechanical properties (i.e. elasticity and weight-bearing capacity), and  
4. physical form permitting application by injection as a paste or gel.  
If these properties could be achieved, bone reconstruction surgery would most probably be 
more cost-effective in the long run; especially because improvement in the patients' quality 
of life would also be achieved. 
In fact, an optimal synthetic bone substitute should be structurally and biomechanically as 
close to surrounding bone as possible. Typically, synthetic bone substitutes are employed in 
the treatment of broken bones in the vertebra, wrist or hip, often due to osteoporosis. In this 
disease, the progressive loss of bone tissue has made the skeleton weaker and more prone to 
fractures, because the amounts of collagen and calcium salts are depleted. In 
vertebroplasty/kyphoplasty, low viscosity bone substitutes are injected into the collapsed 
spinal vertebra in order to stabilize and strengthen the crushed bone (Erbe et al., 2001; Gisep 
et al., 2006). 
As a superior composite (Fig. 6), the synthetic bone substitute would have: (1) tailor-made 
biomechanics, i.e. elasticity and weight-bearing capacity, (2) non-toxicity, (3) bioactivity (i.e. 
osteoconductivity and/or osteoinductivity), (4) porosity of ca. 20-40 vol%, allowing new 
bone ongrowth and ingrowth, (5) possibility to attach/incorporate other substances 
(bioactive glass, growth factor, mesenchymal stem cells, etc.), and (6) physical form 
permitting application by injection/kneading as a paste or gel, and in some cases (7) highly 
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controlled biodegradation by surface erosion mechanism, if the matrix polymer is 
biodegradable and remodelling of new bone is assumed to be sufficient (Aho et al., 2004).  
 
 
Fig. 6. In more sophisticated cases, bone defects can be reconstructed with a mouldable mass 
that is injected into the bone. This kind of dough-like substitute should also contain the 
bioactive substances and pore-generating fillers (Ref. Aho et al., 2004) 
7.2 Challenges of artificial materials for bone reconstruction of arthritic disorders 
Arthritis is a joint disorder featuring inflammation. The two most common types of arthritis 
are osteoarthritis and rheumatoid arthritis that usually involve various joints such as those 
in fingers, spine, legs or arms. Rheumatoid arthritis is an autoimmune inflammatory 
disease, whereas osteoarthritis is mostly related to ageing, but can also be caused by a 
disease. In the case of very severely damaged bone, the only treatment is joint replacement 
surgery. In this, a joint is amputated and replaced with a metallic prosthesis, e.g. in hips or 
knees (Boyer et al., 2009).  
The artificial parts of the prosthesis are often cemented into place by PMMA-based bone 
cement (Lewis 2009). The PMMA-based bone cement layer adheres tightly to the prosthesis 
in the skeleton and acts as an intermediate bumper. Therefore, the patients can normally 
walk with their newly implanted knees or hips very soon after the operation. As medical 
devices, metallic implants, made of stainless steel or titanium, are most frequently used in 
total joint replacements. However, metals exhibits much greater stiffness compared to the 
elasticity of bone. In the fixation of the prosthesis, the large elasticity difference between 
these two materials can cause stress shielding that leads to an increase in bone porosity and 
atrophy. In addition, there are some other clinical problems such as the activation of 
periprosthetic connective tissue, macrophage activation, and bone resorbtion, as well as 
wear and corrosion problems (Santavirta et al., 1998, 1999). Release of nanosized particles of 
metal may also have undesired effects on the biology of tissues. 
The main disadvantage associated with the use of traditional PMMA-based bone cement is 
the anchoring effect that happens only as a mechanical locking, because the surface of the 
polymerised bone cement is of a dense structure that does not allow the bone to grow into 
the cement (i.e. mechanical locking). Therefore, new bone formation is limited only to the 
surface between the bone cement and the bone. If the fixation is only mechanical, the 
micromotion between the bone and the implant interface can lead to resorbtion of bone and 
then the failure and the final loosening of the prosthesis (Santavirta et al., 1998, 1999). 
Therefore, some re-operations of total knee/hip replacement systems have been required 
even within four to eight years after the primary operation (Hooper et al., 2009), although all 
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the prostheses should last for the rest of the patients’ life. To avoid re-operations, these 
prosthetic implant materials should be developed to approximate more closely to the 
properties of bone (e.g. elasticity). 
8. Clinical applications 
A wide range of porous composites for tissue engineering has been studied. In fact, if 
porous scaffolds are utilized effectively in load-bearing applications, the mechanical 
properties of materials with porosity and void spaces should be known. In clinical 
applications, the tailor-made composite structure materials could be employed as follows: 
(1) in osteoarthrosis, (2) in the treatment of osteoporotic fractures, (3) in the controlled filling 
of defects, and (4) as bone grafting materials (Fig. 7).  
In vertebroplasty/kyphoplasty, low viscosity cements, e.g. modified PMMA-based bone 
cements, could be injected into the collapsed spinal vertebra in order to stabilize and 
strengthen the crushed bone (Hulme et al., 2006). Actually, the optimal setting/curing time 
for biomaterials in vertebroplasty is still under investigation. For the application of tissue 
engineering, it should be possible to tailor the curing of materials. In fact, according to our 
studies, this is possible using a specific type of wave energy that increases the 
polymerization of matrix polymer. Thus, the ultimate strength of the substitute can be 
achieved in a couple of minutes after mixing the components. In the fixation of fractures of 
the radius, the better curing would also improve the quality of bone reconstruction. In 
arthroscopic surgery, the injection of bone substitute with controlled curing would probably 
allow the possibility of operating without opening the joint using a micro-invasive 
technique. 
 
 
Fig. 7. Synthetic bone substitutes can be utilized in typical surgical defects of fractured bone. 
Typically, bone defects are reconstructed in the distal radius or vertebra 
Bone fractures and tumour defects often locate in long bone. In the reconstruction of bone, 
autograft bone is assumed to be the best alternative. However, bone defects could also be 
reconstructed using synthetic materials that can interact with biological systems (Lindfors et 
al., 2009). In the case of composites, tailor-made structures could serve as an alternative for 
the traditional implant devices. In contact with living hard tissues, the composite structures 
are able to adapt according to the biological and mechanical requirements. The authors of 
this book chapter have developed new materials and techniques, where the composite 
material will meet the clinical demands including the adjustability and highly controlled 
setting of the material (Aho et al., 2004; Puska et al., 2003, 2004, 2009a). Figure 8 shows one 
example of our experimental materials for bone reconstruction. In our coming papers, these 
new alternatives that have properties like putty form, easy handling and good filling, but 
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are also biomechanically suited to bone tissue, will be presented. In fact, it is predicted that a 
number of autografts will in future be replaced by the more sophisticated biomaterials. 
From the patient’s point of view, this would be a huge improvement. Thus, the mutilation of 
bone and secondary operation would be avoided. 
 
 
Fig. 8. Synthetic reconstruction materials can be utilized as osteoarticlular graft for bone 
tumour surgery. On the right, the image presents a natural rabbit knee joint and beside it an 
artificial joint made of bifunctional polymer composite (Aho et al., 2007) 
9. Summary 
In the biological environment, the demands of biomaterials are challenging. Typically, in the 
reconstruction of bone defects, clinicians use autograft bone, based on the fact that the 
commercially available synthetic materials are not optimal for the reconstruction of bone. 
Nevertheless, calcium-based compounds are generally marketed under several trade names. 
In fact, they are only suitable in a few fixations of bone defect, e.g. to fill the defects in 
cancellous bone. On the other hand, in the case of artificial joint reconstruction, the 
biomechanical properties of inorganic compounds or metallic materials do not respond to 
the demands of bone. In terms of composite structures, bone substitutes can be adjusted to 
be closer to the demands of bone. Thus, polymer composites mimic the structures of bone 
better, because they can be tailor-made to be both osteoconductive and strong enough to 
withstand weight-bearing. These better synthetic bone substitutes will most probably be 
commercially available for orthopaedic applications in the near future. 
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Technological advances in composite field are included in the equipment surrounding us daily; our lives are
becoming safer, hand in hand with economical and ecological advantages. This book collects original studies
concerning composite materials, their properties and testing from various points of view. Chapters are divided
into groups according to their main aim. Material properties are described in innovative way either for standard
components as glass, epoxy, carbon, etc. or biomaterials and natural sources materials as ramie, bone, wood,
etc. Manufacturing processes are represented by moulding methods; lamination process includes monitoring
during process. Innovative testing procedures are described in electrochemistry, pulse velocity, fracture
toughness in macro-micro mechanical behaviour and more.
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